Trump’s second term is beginning in just hours from now. But he’s been put on notice.
Because Donald Trump just received a letter right before inauguration he never saw coming.
Pro-Life OB-GYNS Urge GOP Officials to Prioritize Life-Affirming Policies in Confirmation Hearings
The American Association of Pro-Life OB-GYNS (AAPLOG) has sent a letter to GOP officials urging them to take a firm stance on pro-life issues during the confirmation hearings for several key nominees of President-elect Donald Trump’s administration. The letter, dated Friday, highlights concerns surrounding late-term abortion and the safety of the abortion pill, mifepristone, and calls for stronger regulations on both.
In their letter, AAPLOG implores Republican senators to raise these critical issues with Dr. Marty Makary, Trump’s nominee for the head of the Food and Drug Administration (FDA), Dr. Jay Bhattacharya, the nominee for director of the National Institutes of Health (NIH), and Robert F. Kennedy Jr., who is nominated to lead the Department of Health and Human Services (HHS). The organization advocates for a reconsideration of the approval process for mifepristone, which has faced multiple legal challenges due to concerns about safety and the regulatory process.
“As you know, HHS has the most influential role of any governmental agency over those of us practicing life-affirming medicine and in ensuring the protection of conscience rights,” the letter, shared with the *Daily Caller News Foundation*, states. “As such, the leaders of the Food and Drug Administration, the National Institutes of Health, and HHS overall are vitally important nominees for our confidence in the advancement of life-affirming policies over the next four years. We are heartened to hear the positive reports regarding the meetings many of you have had with these nominees on these topics.”
AAPLOG’s letter urges that the Senate ask the nominees to commit to strengthening safety protocols around mifepristone and reconsider the expansion of telehealth services for prescribing the drug. The group also calls for the nominees to make clear their support for conscience rights for medical professionals and to set a clear gestational limit for abortions. Additionally, they request that the nominees affirm the importance of transparency, rather than ideological influence, in abortion research and data collection.
The letter stresses the necessity of these priorities, especially when it comes to ensuring the safety of both patients and medical practitioners. “As practitioners who are committed to excellent healthcare for all our patients, both born and preborn, these priorities are non-negotiables for us,” the letter reads. “We look forward to the confirmation process and hearing more about these nominees’ positions and commitments to transparency in healthcare and advancing protections for life-affirming medicine, medical professionals, and our patients.”
One of the main concerns raised by AAPLOG involves the safety of mifepristone, the abortion pill. A number of medical professionals have voiced strong opposition to the drug’s approval and distribution, arguing that the FDA bypassed essential safety protocols in order to fast-track its approval. The organization also criticizes the practice of allowing patients to obtain the pill via telehealth services, circumventing direct medical oversight.
Legal Battles Remain On The Horizon For Mass Abortion Pill Proliferation
Legal challenges surrounding mifepristone have also played a role in this ongoing debate. In 2024, the U.S. Supreme Court sided with the FDA in a case involving pro-life plaintiffs, ruling that while the plaintiffs lacked legal standing, they had legitimate moral and policy objections to the drug’s distribution. The court ultimately determined that the issue was not suitable for adjudication at that time, effectively allowing the FDA’s relaxed regulations to remain in place.
Former President Donald Trump has previously stated that, following the fall of Roe v. Wade, he believes abortion decisions should be made at the state level. He has refrained from endorsing a federal ban on abortion, a stance that has sparked varied reactions, including from RFK Jr., who has similarly expressed opposition to federal abortion bans before the point of fetal viability.
In contrast, the Biden administration continued to uphold a pro-abortion position, which has led to significant opposition from pro-life groups. Under the Biden administration, the Department of Justice (DOJ) has been actively involved in prosecuting pro-life activists, particularly those involved in protests outside of abortion clinics.
AAPLOG CEO Dr. Christina Francis spoke to the *Daily Caller News Foundation* about the organization’s hopes for the incoming administration: “After four years of threats to conscience rights and a lack of regard for the health and safety of our patients, we look forward to working with the new administration and finding common ground to improve patient safety,” she said. “These priorities outline real opportunities to improve the lives of our patients and advance life-affirming medical care.”
As the confirmation process moves forward, AAPLOG is closely watching how these nominees will respond to these critical pro-life issues. Their letter serves as a call for more robust discussions on the protection of the unborn and the safety of abortion-related medical practices.
The Federalist Wire will bring you any response from Donald Trump and his team to the letter from Pro-Life groups.
